Your browser doesn't support javascript.
Safety of COVID-19 vaccination in patients with mastocytosis and monoclonal mast cell activation syndrome.
Kaakati, Rayan; Khokhar, Dilawar; Akin, Cem.
  • Kaakati R; Department of Internal Medicine, University of Michigan, Ann Arbor, Mich.
  • Khokhar D; Department of Internal Medicine, Allergy Immunology, University of Michigan, Ann Arbor, Mich.
  • Akin C; Department of Internal Medicine, Allergy Immunology, University of Michigan, Ann Arbor, Mich. Electronic address: cemakin@med.umich.edu.
J Allergy Clin Immunol Pract ; 9(8): 3198-3199, 2021 08.
Article in English | MEDLINE | ID: covidwho-1240411
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Mastocytosis / COVID-19 Type of study: Diagnostic study Topics: Vaccines Limits: Humans Language: English Journal: J Allergy Clin Immunol Pract Year: 2021 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Mastocytosis / COVID-19 Type of study: Diagnostic study Topics: Vaccines Limits: Humans Language: English Journal: J Allergy Clin Immunol Pract Year: 2021 Document Type: Article